NCT02852486 2025-03-30
EDI-PIO
University of Campinas, Brazil
Phase 2 Completed
Clinical Trials
7 trialsNCT02942758 2024-05-08
AML-ViVA
University Hospital Regensburg
Phase 2 Terminated
NCT04883125 2021-05-12
Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
Mansoura University
Phase 2 Completed
NCT02767063 2020-08-07
ACTIW
Versailles Hospital
Phase 1/2 Unknown
NCT02730195 2019-01-09
Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia
Emory University
Phase 2 Terminated
NCT02889003 2018-03-22
PIO2STOP
Versailles Hospital
Phase 2 Unknown
NCT02687425 2016-02-22
SESPI
Tongji Hospital
Phase 2 Unknown